Financials
- Market Capitalization 319.85 M
- Employee 533
- Founded 2002
- CEO N/A
- Website www.vandapharma.com
- Headquarter Delaware, United States
- FIGI BBG000HT5MG6
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.36
市销率
2.41
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3222 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.41 USD | -2.43% | 0.00% | +9.05% | +36.16% | 336.28 M USD | ||
| 3260 | IMRX Immuneering Corporation - Class A Common Stock | 4.99 USD | -4.22% | -5.67% | +22.00% | -11.52% | 322.84 M USD | ||
| 3294 | OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.19 USD | +1.57% | -2.99% | +35.51% | +92.22% | 311.95 M USD | ||
| 3308 | IRD Opus Genetics, Inc. - Common Stock | 3.69 USD | -4.16% | -8.21% | +6.65% | -0.81% | 306.99 M USD |